Consolidated Statement Of Income

STELLA PHARMA CORPORATION - Filing #7371918

Concept 2023-04-01 to
2023-09-30
2022-04-01 to
2022-09-30
Consolidated statement of income
Statement of income
Net sales
153,995,000 JPY
92,397,000 JPY
Cost of sales
30,922,000 JPY
6,373,000 JPY
Operating expenses
Selling, general and administrative expenses
424,305,000 JPY
452,573,000 JPY
Operating expenses
Ordinary profit (loss)
-303,679,000 JPY
-342,330,000 JPY
Gross profit (loss)
123,072,000 JPY
86,023,000 JPY
Operating expenses
Research and development expenses
145,000,000 JPY
119,863,000 JPY
Operating profit (loss)
-301,233,000 JPY
-366,550,000 JPY
Net sales
Non-operating income
857,000 JPY
25,727,000 JPY
Interest income
724,000 JPY
719,000 JPY
Non-operating income
Other
52,000 JPY
4,000 JPY
Selling, general and administrative expenses
Cost of sales
Non-operating expenses
Interest expenses
1,061,000 JPY
1,391,000 JPY
Other
JPY
81,000 JPY
Non-operating expenses
3,303,000 JPY
1,507,000 JPY
Share issuance costs
2,241,000 JPY
JPY
Extraordinary losses
750,000 JPY
JPY
Profit (loss) before income taxes
-304,430,000 JPY
-342,330,000 JPY
Gross profit
Income taxes - current
1,425,000 JPY
1,815,000 JPY
Extraordinary losses
Loss on retirement of non-current assets
750,000 JPY
JPY
Income taxes
1,425,000 JPY
1,815,000 JPY
Profit (loss)
-305,856,000 JPY
-344,145,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.